Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPAR3 | Q9UBY5 | 4/20 | 0.55 |
| ▸ | LPAR2 | Q9HBW0 | 3/20 | 0.55 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.55 |
| ▸ | FAAH | O00519 | 3/20 | 0.54 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.54 |
| ▸ | F7 | P08709 | 1/20 | 0.47 |
| ▸ | F3 | P13726 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | GMNN | O75496 | 1/20 | 0.42 |
| ▸ | USP2 | O75604 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | APEX1 | P27695 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | RECQL | P46063 | 1/20 | 0.42 |
| ▸ | BLM | P54132 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5523012 | 1.00 | LPAR3 (0.55) | LPAR3LPAR2LPAR1FAAHTRPV1 | |
| SCHEMBL31508863 | 1.00 | LPAR3 (0.55) | LPAR3LPAR2LPAR1FAAHTRPV1 | |
| SCHEMBL727768 | 1.00 | LPAR3 (0.55) | LPAR3LPAR2LPAR1FAAHTRPV1 | |
| SCHEMBL10604000 | 1.00 | LPAR3 (0.55) | LPAR3LPAR2LPAR1FAAHTRPV1 | |
| SCHEMBL11072895 | 1.00 | LPAR3 (0.55) | LPAR3LPAR2LPAR1FAAHTRPV1 | |
| SCHEMBL10603998 | 1.00 | LPAR3 (0.55) | LPAR3LPAR2LPAR1FAAHTRPV1 | |
| SCHEMBL11072902 | 1.00 | LPAR3 (0.55) | LPAR3LPAR2LPAR1FAAHTRPV1 | |
| SCHEMBL13048889 | 0.96 | FAAH (0.59) | LPAR3LPAR2LPAR1FAAHTRPV1 | |
| SCHEMBL9618002 | 0.96 | FAAH (0.59) | LPAR3LPAR2LPAR1FAAHTRPV1 | |
| SCHEMBL21642616 | 0.96 | FAAH (0.59) | LPAR3LPAR2LPAR1FAAHTRPV1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250212873-A1 | VOLATILE HDAC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-07-03 | — | — | US | claimed |
| EP-4482306-A1 | VOLATILE HDAC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-01-01 | — | — | EP | claimed |
| WO-2023192424-A1 | VOLATILE HD AC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS CROSS-REFERENCE TO RELATED APPLICATION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-10-05 | — | — | WO | claimed |
| EP-1230207-B1 | METATHESIS SYNTHESES OF PHEROMONES OR THEIR COMPONENTS | PEDERSON RICHARD L (US) | 2005-06-22 | — | — | EP | claimed |
| US-6696597-B2 | CROSS-METATHESIZING A TERMINAL OLEFIN AND INTERNAL OLEFIN IN PRESENCE OF CATALYST, TO FORM METATHESIS PRODUCT AND A SIDE PRODUCT; APPLYING CONDITIONS OF SUFFICIENTLY HIGH TEMPERATURE AND/OR LOW PRESSURE TO EVAPORTE SIDE PRODUCT | TILLIECHEM, INC. | 2004-02-24 | — | — | US | claimed |
| EP-1230207-A2 | METATHESIS SYNTHESES OF PHEROMONES OR THEIR COMPONENTS | Pederson, Richard L. (US) | 2002-08-14 | — | — | EP | claimed |
| US-20020022741-A1 | Metathesis syntheses of pheromones or their components | MATERIA, INC. | 2002-02-21 | — | — | US | claimed |
| WO-2001036368-A2 | METATHESIS SYNTHESES OF PHEROMONES OR THEIR COMPONENTS | PEDERSON RICHARD L (US) | 2001-05-25 | — | — | WO | claimed |
| EP-0099572-B1 | DISPROPORTIONATION OF FUNCTIONAL OLEFINS | PHILLIPS PETROLEUM COMPANY (US) | 1989-09-06 | — | — | EP | claimed |
| US-4560792-A | WITH HYDROCARBYL MONOOLEFIN IN PRESENCE OF TUNGSTEN CARBENE COMPLEX AND HALIDE(OR OXYHALIDE)CATALYST | PHILLIPS PETROLEUM COMPANY (US) | 1985-12-24 | — | — | US | claimed |
| EP-0099572-A1 | Disproportionation of functional olefins | PHILLIPS PETROLEUM COMPANY (US) | 1984-02-01 | — | — | EP | claimed |
| US-20250212873-A1 | VOLATILE HDAC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-07-03 | — | — | US | disclosed |
| EP-4482306-A1 | VOLATILE HDAC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-01-01 | — | — | EP | disclosed |
| US-11779911-B2 | Production of fatty olefin derivatives via olefin metathesis | PROVIVI, INC. (US) | 2023-10-10 | — | — | US | disclosed |
| WO-2023192424-A1 | VOLATILE HD AC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS CROSS-REFERENCE TO RELATED APPLICATION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-10-05 | — | — | WO | disclosed |
| US-4837358-A | Preparation of 9-alkenyl ester compounds | PHILLIPS PETROLEUM COMPANY (US) | 1989-06-06 | — | — | US | disclosed |
| EP-0235742-A1 | Preparation of 9-Alkenyl Ester Compounds | PHILLIPS PETROLEUM COMPANY (US) | 1987-09-09 | — | — | EP | disclosed |
| US-4560792-A | WITH HYDROCARBYL MONOOLEFIN IN PRESENCE OF TUNGSTEN CARBENE COMPLEX AND HALIDE(OR OXYHALIDE)CATALYST | PHILLIPS PETROLEUM COMPANY (US) | 1985-12-24 | — | — | US | disclosed |
| EP-0099572-A1 | Disproportionation of functional olefins | PHILLIPS PETROLEUM COMPANY (US) | 1984-02-01 | — | — | EP | disclosed |
| US-4083995-A | INSECT CONTROL | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) | 1978-04-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11779911-B2 | Production of fatty olefin derivatives via olefin metathesis | SREBF1, F2, SREBF2 | LPAR3 1971/4885LPAR2 2224/4885LPAR1 2254/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.